Table 4.
Total (n=274) | Deaths (n=113) | Recovered patients (n=161) | |
---|---|---|---|
Complications | |||
Acute respiratory distress syndrome | 196 (72) | 113 (100) | 83 (52) |
Type I respiratory failure | 18/67 (27) | 18/35 (51) | 0/32 (0) |
Acute cardiac injury | 89/203 (44) | 72/94 (77) | 18/109 (17) |
With history of hypertension or cardiovascular disease | 47/77 (61) | 37/48 (77) | 11/30 (37) |
Without history of hypertension or cardiovascular disease | 42/126 (33) | 35/46 (76) | 7/80 (9) |
Heart failure | 43/176 (24) | 41/83 (49) | 3/94 (3) |
With history of hypertension or cardiovascular disease | 23/67 (34) | 21/42 (50) | 2/25 (8) |
Without history of hypertension or cardiovascular disease | 21/109 (19) | 20/41 (49) | 1/68 (1) |
Hypoxic encephalopathy | 24 (9) | 23 (20) | 1 (1) |
Sepsis | 179 (65) | 113 (100) | 66 (41) |
Acidosis | 8/67 (12) | 5/35 (14) | 3/32 (9) |
Alkalosis | 19/67 (28) | 14/35 (40) | 5/32 (16) |
Acute kidney injury | 29 (11) | 28 (25) | 1 (1) |
Disseminated intravascular coagulation | 21 (8) | 19 (17) | 2 (1) |
Hyperkalaemia | 62 (23) | 42 (37) | 22 (14) |
Shock | 46 (17) | 46 (41) | 0 (0) |
Acute liver injury | 13 (5) | 10 (9) | 3 (2) |
Gastrointestinal bleeding | 1 (<1) | 1 (1) | 0 (0) |
Treatment | |||
Antiviral therapy | 236 (86) | 89 (79) | 147 (91) |
Glucocorticoid therapy | 217 (79) | 99 (88) | 118 (73) |
Antibiotics | 249 (91) | 105 (93) | 144 (89) |
Intravenous immunoglobulin therapy | 54 (20) | 44 (39) | 59 (37) |
Interferon inhalation | 89 (32) | 25 (22) | 64 (40) |
Oxygen treatment | 251 (92) | 113 (100) | 138 (86) |
High flow nasal cannula | 85 (31) | 77 (68) | 8 (5) |
Mechanical ventilation | 119 (43) | 93 (82) | 26 (16) |
Non-invasive | 102 (37) | 76 (67) | 26 (16) |
Invasive | 17 (6) | 17 (15) | 0 (0) |
Continuous renal replacement therapy | 3 (1) | 3 (3) | 0 (0) |
Extracorporeal membrane oxygenation | 1 (<1) | 1 (1) | 0 (0) |